Outcomes in systemic sclerosis patients hospitalized with COVID-19: Insight from the National Inpatient Sample.
Huzaifa Ahmad CheemaAnum AkhlaqBiah MustafaAbia ShahidMuhammad AyyanEhizogie EdiginPublished in: Journal of scleroderma and related disorders (2023)
COVID-19 patients with systemic sclerosis had worse outcomes (i.e. higher composite endpoint of major adverse events) than those without systemic sclerosis. Further studies are needed to establish a better understanding of the relationship between COVID-19 and systemic sclerosis.
Keyphrases
- systemic sclerosis
- interstitial lung disease
- sars cov
- coronavirus disease
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- mental health
- prognostic factors
- peritoneal dialysis
- palliative care
- respiratory syndrome coronavirus
- metabolic syndrome
- patient reported outcomes
- type diabetes
- adipose tissue